News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
457,499 Results
Type
Article (32276)
Company Profile (42)
Press Release (425182)
Multimedia
Podcasts (63)
Webinars (11)
Section
Business (130815)
Career Advice (645)
Deals (18951)
Drug Delivery (77)
Drug Development (57299)
Employer Resources (76)
FDA (13144)
Job Trends (9556)
News (210306)
Policy (22054)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (1999)
Accelerated approval (37)
ADA (49)
Adcomms (17)
Allergies (162)
Alliances (29039)
ALS (148)
Alzheimer's disease (1246)
Antibody-drug conjugate (ADC) (373)
Approvals (13720)
Artificial intelligence (477)
ASCO (332)
Autoimmune disease (251)
Automation (16)
Bankruptcy (164)
Best Places to Work (7770)
BIO (37)
BIOSECURE Act (11)
Biosimilars (131)
BioSpace Insights (75)
Biotechnology (30)
Bladder cancer (192)
Brain cancer (55)
Breast cancer (605)
Cancer (4969)
Cardiovascular disease (409)
Career advice (595)
Career pathing (20)
CAR-T (236)
CDC (45)
Celiac Disease (3)
Cell therapy (635)
Cervical cancer (47)
Clinical research (51974)
Collaboration (1302)
Commercialization (7)
Company closure (2)
Compensation (373)
Complete response letters (43)
COVID-19 (1811)
CRISPR (71)
C-suite (848)
Cystic fibrosis (90)
Data (7120)
Decentralized trials (2)
Denatured (25)
Depression (139)
Dermatology (98)
Diabetes (515)
Diagnostics (4674)
Digital health (48)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (173)
Drug pricing (173)
Drug shortages (25)
Duchenne muscular dystrophy (178)
Earnings (45723)
Editorial (49)
Employer branding (9)
Employer resources (73)
Events (68471)
Executive appointments (769)
FDA (16554)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (12)
Frontotemporal dementia (19)
Funding (1116)
Gene editing (146)
Generative AI (30)
Gene therapy (453)
GLP-1 (771)
Government (3685)
Grass and pollen (4)
Guidances (305)
Healthcare (14026)
Hematology (142)
HIV (68)
Huntington's disease (32)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (86)
Immunology and inflammation (124)
Immuno-oncology (73)
Indications (186)
Infectious disease (2036)
Inflammatory bowel disease (155)
Inflation Reduction Act (12)
Influenza (83)
Intellectual property (180)
Interviews (59)
IPO (8251)
IRA (44)
Job creations (2032)
Job search strategy (542)
JPM (22)
Kidney cancer (25)
Labor market (57)
Layoffs (242)
Leadership (15)
Legal (4342)
Licensing (6)
Liver cancer (82)
Longevity (16)
Lung cancer (742)
Lymphoma (402)
Machine learning (31)
Management (31)
Manufacturing (564)
Marketing (7)
MASH (162)
Medical affairs (1)
Medical device (13835)
Medtech (14056)
Mergers & acquisitions (11468)
Metabolic disorders (1205)
mRNA (117)
Multiple sclerosis (141)
NASH (12)
Neurodegenerative disease (262)
Neuropsychiatric disorders (70)
Neuroscience (2372)
NextGen: Class of 2026 (4625)
Non-profit (3614)
Now hiring (44)
Obesity (503)
Opinion (154)
Ovarian cancer (199)
Pain (226)
Pancreatic cancer (289)
Parkinson's disease (266)
Partnered (23)
Patents (354)
Patient recruitment (669)
Peanut (53)
People (39642)
Pharmaceutical (16)
Pharmacy benefit managers (27)
Phase 1 (15221)
Phase 2 (22607)
Phase 3 (17978)
Pipeline (7882)
Policy (233)
Postmarket research (2055)
Preclinical (5944)
Press Release (19)
Prostate cancer (294)
Psychedelics (35)
Radiopharmaceuticals (260)
Rare diseases (790)
Real estate (3230)
Recruiting (28)
Regulatory (18659)
Reports (28)
Research institute (1850)
Resumes & cover letters (64)
Rett syndrome (33)
RNA editing (14)
RSV (56)
Schizophrenia (154)
Series A (181)
Series B (127)
Service/supplier (2)
Sickle cell disease (99)
Special edition (12)
Spinal muscular atrophy (116)
Sponsored (20)
Startups (2275)
Stomach cancer (12)
Supply chain (84)
Tariffs (49)
The Weekly (38)
Vaccines (696)
Venture capital (53)
Weight loss (333)
Women's health (105)
Worklife (6)
Date
Today (46)
Last 7 days (312)
Last 30 days (1522)
Last 365 days (18653)
2026 (12091)
2025 (18760)
2024 (22445)
2023 (25707)
2022 (33836)
2021 (36458)
2020 (35719)
2019 (32313)
2018 (24779)
2017 (21026)
2016 (20532)
2015 (23895)
2014 (18209)
2013 (15138)
2012 (16335)
2011 (16788)
2010 (15493)
Location
Africa (452)
Alabama (79)
Alaska (4)
Arizona (276)
Arkansas (13)
Asia (28674)
Australia (4659)
California (8371)
Canada (2608)
China (1265)
Colorado (415)
Connecticut (455)
Delaware (361)
Europe (58022)
Florida (1424)
Georgia (339)
Hawaii (2)
Idaho (40)
Illinois (932)
India (56)
Indiana (524)
Iowa (16)
Japan (493)
Kansas (108)
Kentucky (36)
Louisiana (52)
Maine (33)
Maryland (1208)
Massachusetts (5665)
Michigan (222)
Minnesota (620)
Mississippi (7)
Missouri (109)
Montana (21)
Nebraska (24)
Nevada (103)
New Hampshire (79)
New Jersey (2781)
New Mexico (15)
New York (2454)
North Carolina (1175)
North Dakota (6)
Northern California (4177)
Ohio (297)
Oklahoma (15)
Oregon (30)
Pennsylvania (1857)
Puerto Rico (18)
Rhode Island (39)
South America (691)
South Carolina (83)
Southern California (3420)
Tennessee (201)
Texas (1565)
United States (32085)
Utah (270)
Vermont (1)
Virginia (245)
Washington D.C. (67)
Washington State (635)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
457,499 Results for "american medical depot".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mapi Pharma Announces Initial Phase I/IIa Clinical Results Supporting Continued Development of Once-Monthly Cariprazine Depot
August 12, 2026
·
3 min read
Press Releases
Picard Medical Receives NYSE American Acceptance of Compliance Plan
July 27, 2026
·
4 min read
Press Releases
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
June 30, 2026
·
6 min read
Press Releases
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance
July 22, 2026
·
5 min read
Press Releases
Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger
July 2, 2026
·
6 min read
Press Releases
Mapi Pharma to Present Efficacy (EDSS) Data from Glatiramer Acetate Depot Long-Acting Injection Studies in Relapsing Forms of Multiple Sclerosis (RMS) and Primary Progressive Multiple Sclerosis (PPMS) at AAN 2026
April 17, 2026
·
3 min read
Press Releases
Mapi Pharma to Host Virtual KOL Event to Discuss Glatiramer Acetate Once a Month Depot for Primary Progressive Multiple Sclerosis, on March 3, 2026
February 19, 2026
·
6 min read
Press Releases
LUPRON DEPOT® new strength receives Health Canada Approval for the Treatment of Advanced Prostate Cancer
November 18, 2025
·
4 min read
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
Sponsored
How AI-enabled Software as Medical Devices are Reshaping Regulatory Routes and Medicine
As AI-enabled Software as Medical Devices become more prevalent, regulatory agencies are responding with new guidelines and AI-specific authorisation routes. This article looks at current trends, suggests clinical considerations for medical device developers and anticipates AI-enabled SaMDs’ future progress.
August 17, 2026
·
6 min read
·
JoAnne Bronikowski
1 of 45,750
Next
